The role of platelet and plasma markers of antioxidant status and oxidative stress in thrombocytopenia among patients with vivax malaria

ARTICLES

The role of platelet and plasma markers of antioxidant status and oxidative stress in thrombocytopenia among patients with vivax malaria

Claudio F Araujo^I; Marcus VG Lacerda^II; Dulcineia SP Abdalla^III; Emerson S LimaI, ⁺

^IFaculdade de Ciências Farmacêuticas, Universidade Federal do Amazonas, Manaus, AM, Brasil

^IILaboratório de Malária, Fundação de Medicina Tropical do Amazonas, Manaus, AM, Brasil

^IIIDepartmento de Análises Clínicas e Toxicológicas, Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, São Paulo, SP, Brasil

ABSTRACT

Malaria remains an important health problem in tropical countries like Brazil. Thrombocytopenia is the most common hematological disturbance seen in malarial infection. Oxidative stress (OS) has been implicated as a possible mediator of thrombocytopenia in patients with malaria. This study aimed to investigate the role of OS in the thrombocytopenia of Plasmodium vivax malaria through the measurement of oxidant and antioxidant biochemical markers in plasma and in isolated platelets. Eighty-six patients with P. vivax malaria were enrolled. Blood samples were analyzed for total antioxidant and oxidant status, albumin, total protein, uric acid, zinc, magnesium, bilirubin, total thiols, glutathione peroxidase (GPx), malondialdehyde (MDA), antibodies against mildly oxidized low-density lipoproteins (LDL^-/nLDL ratio) and nitrite/nitrate levels in blood plasma and GPx and MDA in isolated platelets. Plasma MDA levels were higher in thrombocytopenic (TCP) (median 3.47; range 1.55-12.90 µmol/L) compared with the non-thrombocytopenic (NTCP) patients (median 2.57; range 1.95-8.60 µmol/L). Moreover, the LDL^-/nLDL autoantibody ratio was lower in TCP (median 3.0; range 1.5-14.8) than in NTCP patients (median 4.0; range 1.9-35.5). Finally, GPx and MDA were higher in the platelets of TPC patients. These results suggest that oxidative damage of platelets might be important in the pathogenesis of thrombocytopenia found in P. vivax malaria as indicated by alterations of GPx and MDA.

Key words: malaria - oxidative stress - platelet - thrombocytopenia - malondialdehyde - glutathione peroxidase

Reactive oxygen (ROS) or nitrogen species (RNS) are considered to play diverse roles in many aspects of physiological and pathological events (Akaike & Maeda 2000). When pro-oxidants increase or antioxidants fall, oxidative stress (OS) ensues that leads to excessive molecular damage and tissue injury (Januel et al. 2006). However, OS has been defined as an imbalance of increased oxidants and decreased antioxidants. During metabolism, aerobic organisms form ROS, such as anion radical superoxide (O₂^•¯), hydrogen peroxide (H₂O₂), hypochlorous acid, hydroxyl (^•OH), hydroperoxyl or RNS such nitric oxide (NO^•), nitrogen dioxide radical and anion peroxynitrite. These radicals are constantly produced during normal aerobic metabolism and are safely removed by a variety of biological endogenous and exogenous antioxidants (Gutteridge 1995). OS can be measured in biological fluids by analysis of endogenous products of lipid peroxidation such as malondialdehyde (MDA) or by measurement of enzymes involved in antioxidant mechanisms. MDA is an endogenous aldehyde produced by fatty acid oxidation and has been used as marker of OS. Glutathione peroxidase (GPx) is a selenium-dependent and lipid peroxide-scavenging enzyme that effectively reduces lipid peroxides with the concomitant oxidation of glutathione. Its activity can be altered under OS conditions (Gutteridge 1995).

Activated phagocytes produce ROS and RNS that help to kill some types of microorganisms. However, the method by which these species destroy microorganisms remains unclear; both direct oxidative damage and indirect damage (whereby reactive species promote the actions of other antibacterial agents) are involved, and no single mechanism is likely to account for the killing of all microorganisms. Neutrophils, monocytes, eosinophils and macrophages respond to appropriate stimuli by a marked increase in O₂ uptake, termed the respiratory burst (Halliwell 2006).

The presence of OS during malaria infection is already known, although not totally understood. Either a protective or deleterious role of this OS seems to occur in patients with malaria (Pabón et al. 2003). Malarial infection induces the generation of ^•OH radical in the liver, which may be responsible for the induction of OS and apoptosis (Guba et al. 2006). NO^• is a molecule that has been proposed to have a crucial role in malaria pathogenesis (Sobolewscki et al. 2005). The malaria parasite itself is reported to generate large quantities of H₂O₂ and O₂ (Hunt & Stocker 1990, Mishra et al. 1994).

The mechanism of thrombocytopenia in malaria is not clearly known and OS may play a role in this process. ROS species may have important functions in the structural and functional alterations of platelets and in the mechanism of trombocytopenia in malaria (Erel et al. 2001). To characterize the role of OS in thrombocytopenia mediated by P. vivax infection, markers of OS and antioxidant status were analyzed in blood plasma and platelets of patients with vivax malaria.

SUBJECTS, MATERIALS AND METHODS

Subjects - The study population was constituted of outpatients with acute febrile syndrome attending the Fundação de Medicina Tropical do Amazonas (FMT-AM), from March-October 2006. Exclusion criteria were pregnancy and current use of antimalarials. A total of 86 patients (60 male and 26 female) between the ages of 18-60 years with P. vivax malaria were randomly enrolled in the study. Randomization was performed through the selection of patients with the diagnosis of malaria by thick blood smear arriving at the FMT-AM, using a random-digit table. The diagnosis was made initially by a routine thick blood smear and confirmed a posteriori by polymerase chain reaction (Snounou et al. 1993). All the individuals completed a written informed consent form. The study was approved by the Ethics Committee Board of the FMT-AM.

Blood and platelet samples - Venous blood was collected in K₂EDTA Vacutainer^® tubes for automatized platelet count. Thrombocytopenia was defined as platelet count under 150,000/µL. Venous blood samples were also collected in Vacutainer^® tubes containing sodium citrate (0.15%). Blood was centrifuged at 500 rpm for 5 min at rt to obtain platelet-rich plasma (PRP). The platelets were washed three times at 2,000 rpm for 10 min. After each centrifugation, the supernatant was decanted and discarded, and the platelet pellet was resuspended into 500 µL of a sodium chloride solution (0.89%) and immediately refrigerated at 4ºC until the biochemical assays were performed. Platelet-poor plasma was separated from the remaining blood after the PRP separation by centrifugation at 3,500 rpm by 10 min.

Biochemical assays - The concentrations of total protein, albumin (ALB), uric acid (UA), total bilirubin (TB), conjugated bilirubin (CB) and magnesium were measured in blood plasma by using commercial kits (Labtest Diagnóstica^®, Minas Gerais, Brazil). Zinc concentration and GPx activity in plasma and platelets were measured with commercially available reagent kits (Randox Laboratories LTDA^®). All measurements were made with an automatic chemical analyzer (Cobas Mira Plus^®, Roche Diagnostic Systems^®, Inc, Branchburg, NJ).

Markers of OS and antioxidant status - The concentration of total sulfhydryl (SH) groups was measured according to Ellman (1959) and Hu (1994) adapted to an autoanalyzer (Cobas Mira Plus^®) as described by Costa et al. (2006). The total antioxidant status (TOS) of blood plasma was measured with 2, 2-azinobis 3-ethylbenzothiazoline-6-sulfonate (Erel 2004). The TOS was measured as described by Erel (2005). MDA levels were determined by the TBARs spectrophotometric test (Esterbauer & Cheeseman 1990). Antibodies against mildly oxidized low-density lipoproteins (LDL^-) and native LDL (nLDL) were determined by enzyme-linked immunosorbent assay according to Oliveira et al. (2006) and expressed as LDL^-/nLDL autoantibody ratios. Nitrite/Nitrate concentrations were measured by chemiluminescence in the gas phase (NOA 280^®, Sievers, Boulder, CO, USA) after reduction with acidic vanadium (III) chloride.

Statistical analysis - Parameters are shown as mean ± standard deviation or median and range. Student's t test was used to estimate differences of means. Mann-Whitney rank sum test was used when the data were not normally distributed. Correlations were examined by the Pearson correlation test when the data were normally distributed. Analyses were performed with Epi Info 3.3 (CDC/Atlanta). Statistical significance was assumed when p < 0.05.

RESULTS

Thrombocytopenia (platelet count < 150,000/µL) was found in 72% of the malaria patients. The patients were classified as non-thrombocytopenic (NTCP) or orthrombocytopenic (TCP). The comparison between plasma biochemical markers in the two groups is shown in Table. In the TCP group, TB, CB and MDA concentrations were higher than in NTCP subjects (p < 0.05). Moreover, the LDL^-/nLDL autoantibody ratio was lower in TCP compared to NTCP patients. There was a negative correlation between platelet count and time of infection, parasitaemia, TB, platelet GPx and platelet MDA level (p > 0.05). MDA concentration (Fig. 1) and GPx activity (Fig. 2) were higher in the platelets of TCP patients. Fig. 3 shows the negative correlations between platelet number and platelet MDA concentrations (r = -0.701; p = < 0.001) (Fig. 3A); platelet number and platelet GPx levels (r = -0.737; p = < 0.001) (Fig. 3B); and platelet GPx activity and platelet MDA concentration (r = 0.961; p = < 0.001) (Fig. 3C).

DISCUSSION

The aim of this study was to investigate the role of OS and antioxidant status in thrombocytopenia mediated by P. vivax infection. In order to achieve this objective, markers of OS and antioxidant status were analyzed in plasma and platelets of TCP and NTCP patients. Plasma MDA levels were higher in TCP when compared with the NTCP patients. Moreover, the LDL^-/nLDL auto-antibody ratio was lower in TCP than in NTCP patients. Also, importantly, GPx and MDA were higher in platelets of TCP patients.

Thrombocytopenia has long been observed in human and animal malaria infection (Osim et al. 1991). Several mechanisms have been suggested for this thrombocytopenia, including disseminated intravascular coagulation, immune mechanisms due to absorption of soluble malaria antigen by platelets and subsequent attachment of antibodies to such antigens. Other factors suggested are defective platelet formation and hypersplenism and OS. However, the exact mechanism has not been elucidated (Abdalla 1990, Kumar & Shashirekha 2006).

Human plasma protection against free radical injury is offered by a wide spectrum of antioxidants with synergic action; individual measurements of antioxidant concentrations in blood do not always reflect the level of antioxidant status. We showed that the total plasmatic antioxidant capacity was not decreased in TCP patients, despite the low levels of ALB and thiol groups, which demonstrates an adequate capacity of plasma to protect its environment from free radical aggression. As the TOS activity of human plasma is mainly attributable to UA, protein thiol groups, and bilirubin (Halliwell & Gutteridge 1999), the low plasma levels of thiols and the increase in UA concentrations found in plasma of patients with malaria might account for the maintenance of the overall redox network in plasma of these patients. In the present study, although not statistically different, in the TCP group, total plasma thiols, a parameter of non-oxidation of SH groups, were lower than in the NTCP patients. This could be suggestive of a decrease in antioxidant protection in these subjects.

In the present study, we found that plasma MDA levels of TCP were higher than those of NTCP. The increased plasma MDA concentration in TCP suggests the role of free radicals in the pathogenesis of this disease. Despite the possible interference of bilirubin in the MDA measurement, no correlation was observed between total plasmatic bilirubin and MDA in our sample (Pearson´s test; r = 0.188; p = 0.211). This means that in the present study bilirubin did not interfere in MDA results.

The electronegative LDL (LDL^-) is a pro-inflammatory LDL subfraction that has been related to OS (Da-masceno et al. 2006). In the present study, the auto-antibodies reactive to LDL^-, expressed as the ratio between antibodies anti-LDL^- and anti-native LDL, were lower in TCP than in NTCP. However, the amount of anti-native LDL was 2.5 times higher in TCP, which is probably due to the polyclonal B cell activation observed in chronic malaria infection (Donati et al. 2006).

Platelet membranes are less resistant to OS and the membranes of platelets are thinner than those of erythrocytes. While some erythrocytes are being lysed, the lysis of platelets will also be unavoidable. It is expected that increased OS may lead to increase in platelet lysis. Erel et al. (2001) found that platelet count, platelet superoxide dismutase (SOD) and GPx activities of patients with vivax malaria were lower and platelet lipid peroxidation levels were higher than normal controls, thus suggesting OS as a possible cause of thrombocytopenia. Ohyashiki et al. (1991) showed that platelet lipid peroxidation increase when rat platelets were exposed to free oxygen radicals, what parallels the decrease of platelet aggregation capacity. Sohail et al. (2007) found higher lipid peroxidation levels in P. vivax infected patients than in healthy subjects. It is feasible that a significant amount of MDA generated during malaria infection can be due to activation of the immune response (Pabón et al. 2003). The increase in lipid peroxidation is probably due to the production of ROS species by the immune cells and also due to the synchronized release of O^-₂ during hemoglobin degradation by the malarial parasite. It has been shown that intact Plasmodium falciparum trophozoite infected human red cells produce H₂O₂ and OH^- radical about twice as much as the normal erythrocyte (Sohail et al. 2007).

The deficiency of selenium may result in an ineffective antioxidant system, e.g., low levels of GPx (Akaike & Maeda 2000). In order to maintain a redox equilibrium, malaria parasites are equipped with a range of low weight antioxidants, the most prominent being the tripeptide glutathione, as well as with antioxidant enzymes (Becker et al. 2004). In the present work, increased GPx was found in the platelets of thrombocytopenic patients that is in accordance with previously reported data. Pabón et al. (2003) showing increased activities of GPx, SOD and total antioxidant status (CAT) in malaria patients. This suggests that the increased GPx levels found here may represent a compensatory response to increased OS in thrombocytopenic patients as indicated by their high amount of platelet MDA. We also demonstrated that levels of platelet GPx, as well as platelet MDA, are negatively correlated with platelet number in P. vivax malaria infection. GPx, CAT and SOD are the primary intracellular antioxidant defense mechanism against OS. Both GPx and CAT have the ability to inactivate the intracellular H₂O₂. GPx has been considered the preferential pathway for elimination of low concentrations of H₂O₂ (Jakob & Jandl 1966). Pabón et al (2003) reported similar data showing increment of MDA/GPx ratio (caused by increase of both MDA and GPx) in patients with malaria, suggesting that this may be a consequence of an augmentation of lipid peroxidation (high MDA levels) followed by increased GPx synthesis and activity. The increase of GPx could also be due to the fact that Plasmodium produces GPx in response to ROS species formed during hemoglobin degradation (Ginsburg & Atamna 1997, Gamain et al. 1999). It is clear that MDA/GPx ratios are affected in malaria patients; this supports the concept that a great amount of free radicals are generated during malaria infection, which are responsible for changes in the activity of antioxidant enzymes.

Thus, among the variety of mechanisms postulated as the cause of thrombocytopenia in malaria, none have been unequivocally proven. It is possible that several of these factors are responsible acting together. OS has been proposed as an underlying mechanism that contributes to endothelial dysfunction associated with malaria. The clinical significance of this pathogenic pathway remains to be substantiated, because no general consensus on the existence of systemic oxidant stress in malaria has yet been attained. Free oxygen radicals may play an important role in structural and functional damages of platelets and in the mechanism of thrombocytopenia.

In conclusion, our results suggest that MDA and GPx are important markers of platelet OS in malaria caused by P. vivax and could be implicated in the mechanisms of malaria-induced thrombocytopenia. Further studies are needed in order to clarify the differences of the association of OS and thrombocytopenia between patients with P. falciparum and P. vivax malaria.

ACKNOWLEDGEMENTS

To Miss Carolina Marinho da Costa, for her technical assistance, to the patients and the personnel of the Fundação de Medicina Tropical do Amazonas and to the group of the Laboratório de Bioquímica do Departmento de Análises Clínicas Universidade de São Paulo.

Received 1 October 2007

Accepted 8 September 2008

Financial support: CNPq (Millennium Group, Redoxoma)

• Abadalla SH 1990. Hematopoiesis in human malaria. Blood Cells 16: 401-416.
• Akaike T, Maeda H 2000. Nitric oxide and virus infection. Immunol 100: 300-308.
• Becker K, Tilley L, Vennerstrom JL, Roberts D, Rogerson S, Ginsburg H 2004. Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions. Int J Parasitol 34: 163-189.
• Costa CM, Santos RCC, Lima ES 2006: A simple automated procedure for thiol measurement in human serum samples. J Bras Patol Med Lab 42: 339-344.
• Damasceno NR, Sevanian A, Apolinário E, Oliveira JM, Fernandes I, Abdalla DSP 2006. Detection of electronegative low density lipoprotein (LDL-) in plasma and atherosclerotic lesions by monoclonal antibody-based immunoassays. Clin Biochem 39: 28-38.
• Donati D, Mok B, Chêne A, Xu H, Thangarajh M, Glas R, Chen R, Wahlgren M, Bejarano MT 2006. Increased B cell survival and preferential activation of the memory compartment by a malaria polyclonal B cell activator. J Immunol 177: 3035-3044.
• Ellman GL 1959. Tissue sulfhydryl groups. Arch Biochem Biophys 82: 70-77.
• Erel O 2004. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 37: 277-285.
• Erel O 2005. A new automated colorimetric method for measuring total antioxidant status. Clin Biochem 38: 1103-1111.
• Erel O, Vural H, Aksoy N, Aslan G, Ulukanligil M 2001. Oxidative stress of platelets and thrombocytopenia in patients with vivax malaria. Clin Biochem 34: 341-344.
• Esterbauer H, Cheeseman KH 1990. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 186: 407-421.
• Guba M, Kumar S, Choubey V, Maity P, Bandyopadhyay U 2006. Apoptosis in liver during malaria: role of oxidative stress and implication of mi tochondrial pathway. FASEB J 20: 1224-1226.
• Gutteridge JMC 1995. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 41: 1819-1828.
• Halliwell B 2006. Phagocyte-derived reactive species: salvation or suicide? Trends Biochem Sci 31: 509-515.
• Hu ML 1994. Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol 233: 380-385.
• Hunt NH, Stocker R 1990. Oxidative stress and the redox status of malaria-infected erythrocytes. Blood Cells 16: 499-526.
• Jacob HS, Jandl JH 1966. Effects of sulphydryl inhibition on red blood cells. II Glutathione in the regulation of the hexoses monophosphate pathway. J Biol Chem 241: 4243-4250.
• Januel C, El Hentati FZ, Carreras M, Arthur JR, Calzada C, Lagarde M, Vericel E 2006. Phospholipid-hydroperoxide glutathione (GPx-4) localization in resting platelets, and compartmental change during platelet activation. Biochim Biophys Acta 1761: 1228-1234.
• Kumar A, Shashirekha 2006. Thrombocytopenia - an indicator of acute vivax malaria. Indian J Pathol Microbiol 49: 505-508.
• Mishra NC, Kabilan L, Sharma A 1994. Oxidative stress and malaria-infected erythrocytes. Indian J Malariol 31: 77-87.
• Ohyashiki T, Kobayashi M, Matsui K 1991. Oxygen radical mediated lipid peroxidation and inhibition of ADP-induced platelet aggregation. Arch Biochem Biophys 288: 282-286.
• Oliveira JA, Sevanian A, Rodrigues RJ, Apolinario E, Abdalla DSP 2006. Minimally modified electronegative LDL and its autoantibodies in acute and chronic coronary syndromes. Clin Biochem 39: 708-714.
• Osim EE, Adegunloye BJ, Emeribe AO 1991. In vivo platelet aggregation in acute malaria. Acta Tropica 49: 227-232.
• Pabón A, Carmona J, Burgos LC, Blair S 2003. Oxidative stress in patients with non-complicated malaria. Clin Biochem 36: 71-78.
• Snounou G, Viriyakosol S, Zhu XP, Jarra W, Pinheiro L, Rosario VE, Thaithong S, Brown KN 1993. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol Biochem Parasitol 61: 315-320.
• Sobolewscki P, Gramaglia I, Frangos J, Intaglietta M, van der Heyde HC 2005. Trends Parasitol 21: 415-422.
• Sohail M, Kaul A, Raziuddin M, Adak T 2007. Decreased glutathione-S-transferase activity: Diagnostic and protective role in vivax malaria. Clin Biochem 40: 377-382.

Publication Dates

• Publication in this collection
  16 Oct 2008
• Date of issue
  Sept 2008

History

• Accepted
  08 Sept 2008
• Received
  01 Oct 2007